Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
IIV<sup>33,34</sup> may be used (if RIV3 unavailable), but should be given by a clinician familiar w/ potential egg allergy manifestations, and recipients observed for at least 30 min<sup>35</sup>
By
rray
, 10 October, 2014
Exclude Patient Type Detail Header
No
Detail Type
Text
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube